temozolomide has been researched along with Craniopharyngioma, Adamantinous in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Temozolomide is an alkylating chemotherapeutic agent used routinely in the management of high grade gliomas." | 1.37 | MGMT immunoexpression in adamantinomatous craniopharyngiomas. ( Altuntaş, Y; Aydın, Y; Karaman, O; Müslüman, AM; Ozderya, A; Ozkayalar, H; Oztürk, FY; Tanık, C; Zuhur, SS, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Raverot, G | 1 |
| Ilie, MD | 1 |
| Lasolle, H | 1 |
| Amodru, V | 1 |
| Trouillas, J | 1 |
| Castinetti, F | 1 |
| Brue, T | 1 |
| Zairi, F | 1 |
| Aboukais, R | 1 |
| Maurage, CA | 1 |
| Assaker, R | 1 |
| Zuhur, SS | 1 |
| Müslüman, AM | 1 |
| Tanık, C | 1 |
| Karaman, O | 1 |
| Oztürk, FY | 1 |
| Ozderya, A | 1 |
| Ozkayalar, H | 1 |
| Aydın, Y | 1 |
| Altuntaş, Y | 1 |
1 review available for temozolomide and Craniopharyngioma, Adamantinous
| Article | Year |
|---|---|
Aggressive pituitary tumours and pituitary carcinomas.
Topics: Craniopharyngioma; Humans; Immunotherapy; Pituitary Neoplasms; Temozolomide; Tumor Microenvironment | 2021 |
2 other studies available for temozolomide and Craniopharyngioma, Adamantinous
| Article | Year |
|---|---|
Glioblastoma occurring after the surgical resection of a craniopharyngioma.
Topics: Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemoradiotherapy; Clinical Protocols; Cra | 2014 |
MGMT immunoexpression in adamantinomatous craniopharyngiomas.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Biomarkers, Pharmacological; Biomarkers, Tumor | 2011 |